Skip to main content
Premium Trial:

Request an Annual Quote

Cannabis Sciences Startup Dewey Scientific Raises $1.3M

NEW YORK — Cannabis sciences firm Dewey Scientific said today that it has raised roughly $1.3 million in seed funding in a round led by undisclosed private investors.

The Pullman, Washington-based company was founded last year by Washington State University scientists to offer molecular breeding and genomic services for cannabis cultivation.

"While more established crops have benefitted from genomics and advanced breeding methods, the prohibition of cannabis has created a gap in available technology," Dewey Scientific Cofounder Paul Mihalyov said in a statement. "We are providing industrial cannabis farmers with the same scientific resources that are available to Washington's other top agricultural commodities like wheat, hops, and apples."

Washington State legalized cannabis for medical use in 1998 and for recreational use in 2012.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.